Canada’s psilocybin rules are stricter than many people assume, but there are real legal pathways for patients and researchers. This guide breaks down Section 56 exemptions, Health Canada’s Special Access Program, clinical trial access, and the practical limits every Canadian should understand before pursuing psilocybin legally.
Tag Archives: Special Access Program
Psilocybin Gummies: Ingredients, Health Risks and Legal Facts Psilocybin gummies are edible products described as containing psilocybin, a psychedelic compound found in certain mushroom species. However, a product name or package claim does not independently establish what a gummy contains. Some mushroom-labelled edibles contain different psychoactive substances, while others contain non-psychedelic mushroom ingredients. For readers […]


